World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 115 4424 4148 88 84 581 84132

Lars Rydén publications per year

The chart shows the history of publications by Lars Rydén between 1969 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Lars Rydén published across 58 years, from 1969 to 2026, averaging 10.6 papers a year. Output peaked at 30 publications in 2009. 5 of the 612 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1969 to 2026. Vertical axis: number of publications, 0 to 30. Peak 30 publications in 2009. 1969: 1 publication 1970: 1 publication 1971: 1 publication 1972: 3 publications 1973: 3 publications 1974: 0 publications 1975: 7 publications 1976: 1 publication 1977: 3 publications 1978: 1 publication 1979: 2 publications 1980: 5 publications 1981: 3 publications 1982: 4 publications 1983: 8 publications 1984: 2 publications 1985: 4 publications 1986: 3 publications 1987: 5 publications 1988: 5 publications 1989: 5 publications 1990: 8 publications 1991: 10 publications 1992: 11 publications 1993: 6 publications 1994: 7 publications 1995: 12 publications 1996: 17 publications 1997: 10 publications 1998: 14 publications 1999: 24 publications 2000: 24 publications 2001: 15 publications 2002: 11 publications 2003: 14 publications 2004: 16 publications 2005: 12 publications 2006: 13 publications 2007: 18 publications 2008: 13 publications 2009: 30 publications 2010: 15 publications 2011: 19 publications 2012: 21 publications 2013: 21 publications 2014: 15 publications 2015: 10 publications 2016: 20 publications 2017: 19 publications 2018: 20 publications 2019: 25 publications 2020: 23 publications 2021: 23 publications 2022: 13 publications 2023: 9 publications 2024: 2 publications 2025: 2 publications 2026: 3 publications
1969 2026

612 publications in total across all disciplines

View publications per year as a table
Lars Rydén: publications per year, 1969 to 2026
Year Publications
1969 1
1970 1
1971 1
1972 3
1973 3
1974 0
1975 7
1976 1
1977 3
1978 1
1979 2
1980 5
1981 3
1982 4
1983 8
1984 2
1985 4
1986 3
1987 5
1988 5
1989 5
1990 8
1991 10
1992 11
1993 6
1994 7
1995 12
1996 17
1997 10
1998 14
1999 24
2000 24
2001 15
2002 11
2003 14
2004 16
2005 12
2006 13
2007 18
2008 13
2009 30
2010 15
2011 19
2012 21
2013 21
2014 15
2015 10
2016 20
2017 19
2018 20
2019 25
2020 23
2021 23
2022 13
2023 9
2024 2
2025 2
2026 3
Total 612
Download as CSV

Lars Rydén publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars Rydén sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 581–600 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 581 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509 581
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Lars Rydén D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Rydén sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 114–115 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393 115
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Lars Rydén is affiliated with the Karolinska Institute in Sweden, with a research focus primarily in the fields of Medicine, Endocrinology, Diabetes and Metabolism, and Cardiology and Cardiovascular Medicine. Their body of work also spans Epidemiology, Physiology, and Molecular Biology. The main topics addressed in their research include diabetes treatment and management, atrial fibrillation management and outcomes, diet and metabolism studies, metabolism related to diabetes and cancer, antiplatelet therapy and cardiovascular diseases, cardiovascular function and risk factors, as well as diabetes management and research.

Rydén's recent publications demonstrate a focus on diabetes, cardiovascular health, and cognitive outcomes. Noteworthy papers include:

  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial (2020, The Lancet Neurology)
  • Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial (2022, European Journal of Heart Failure)
  • The history of the Nobel prize for the discovery of insulin (2021, Diabetes Research and Clinical Practice)
  • Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline (2020, Stroke)
  • Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial (2022, European Heart Journal - Cardiovascular Pharmacotherapy)

Frequent collaborators include Giulia Ferrannini, Linda Mellbin, Anna Norhammar, Jeffrey L. Probstfield, and Gilles R. Dagenais, each contributing to multiple joint publications with Rydén.

The scientist's work has been published regularly in several venues with Cardiovascular Diabetology and European Heart Journal each hosting four of their papers, Diabetes Research and Clinical Practice presenting three, and single publications appearing in The Lancet Neurology and European Journal of Heart Failure.

Best Publications

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    J Perk;G De Backer;H Gohlke;I Graham

  • Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

    J. S. Alpert;E. Antman;F. Apple;P. W. Armstrong

  • ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

    Lars Ryden;Peter J. Grant;Stefan D. Anker;Christian Berne

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

    Klas Malmberg;Lars Rydén;Suad Efendic;Johan Herlitz

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

    Milton Packer;Philip A. Poole-Wilson;Paul W. Armstrong;John G. F. Cleland

  • Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

    Anna Norhammar;Åke Tenerz;Göran Nilsson;Anders Hamsten

  • Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

    K Malmberg;Lars Rydén;H Wedel;K Birkeland

  • Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

    Å Hjalmarson;Johan Herlitz;I Málek;L Rydén

  • 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

    Massimo F. Piepoli;Arno W. Hoes

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    L. Samuel Wann;Anne B. Curtis;Kenneth A. Ellenbogen;N.A. Mark Estes

  • Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study

    Klas Malmberg;Anna Norhammar;Hans Wedel;Lars Rydén

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

    Joep Perk;Guy De Backer;Helmut Gohlke;Ian Graham

  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

Frequent Co-Authors

David R. Wood
David R. Wood Monash University
Dirk De Bacquer
Dirk De Bacquer Ghent University
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Jeffrey L. Probstfield
Jeffrey L. Probstfield University of Washington
Renata Cifkova
Renata Cifkova Charles University
Guy De Backer
Guy De Backer Ghent University
Rafael Diaz
Rafael Diaz University of Alberta
Salim Yusuf
Salim Yusuf McMaster University
Kerstin Brismar
Kerstin Brismar Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to various related fields and flexible online degree options. For those interested in leadership roles within healthcare, earning an accelerated healthcare administration degree can be a fast track to management positions and policy roles in hospitals or clinics.

Registered nurses aiming to become nurse practitioners can benefit from adn to np programs online. These bridge programs allow working nurses to advance their education and clinical skills while maintaining their careers.

For those passionate about nutrition and preventative care, an online dietitian degree provides a convenient path to becoming a certified dietitian or nutritionist. This specialty is vital for supporting patient health and wellness in a variety of settings.

If your ambition is to lead in healthcare administration, consider one of the top cahme-accredited mha programs online. These programs are recognized for their rigorous standards and prepare graduates for executive roles across healthcare organizations.

Exploring these online degrees can expand your career options and allow you to make a meaningful difference in the healthcare field.

Best Scientists Citing Lars Rydén

Trending Scientists

Recently Published Articles